Blog Layout
Disrupting healthcare: Integration of Medicinal Cannabis
Staff Writers
Ian Brighthope built an integrative medicine empire, and has now created a global cannabis company, pushing to be at the forefront of the Australian export market
Medicinal cannabis is on a stratospheric rise globally. For most Western nations, legalisation is now a question of when, and not if. In Australia, the ACT has already decriminalised the growing, possession, and recreational use of the plant.
Considering Australia’s ideal climate and skilled agricultural workforce to grow cannabis, there is a massive market opportunity that awaits domestically, and as an export product.
For Prof. Ian Brighthope , the founder of Nutrition Care Pharmaceuticals, Biocentres Clinics and the post-graduate Australasian College of Nutritional and Environmental Medicine, the real opportunity lies in cannabis as a complementary medicine. A local industry could tap into massive Asian market which has a huge appetite for herbal remedies.
Few in the complementary and nutritional medicine space have the credentials of Ian Brighthope. Nutrition Care was the first Australian exporter of health care products to China, and also exports to Indonesia, Thailand, Poland, Singapore, Malaysia and New Zealand.
Dr. Brighthope’s new company, Entoura, is set to leverage his long history and connections in the region to break into the market, with Nutrition Care Pharmaceuticals having been selling medicines to China for decades.
As he explains, “When China opens, we will have a ready made market, as we are the only market in the region that can do so. China respects Australian products as we have extremely rigorous standards for herbal medicine manufacturing.”
Combined with Dr. Brighthope’s knowledge and passion for nutritional and integrative medicine, the company is set to take a highly-focused approach to the plant. While approving products for pharmaceutical use is an extremely long, expensive process, selling herbal remedies is much simpler.
By incorporating the best parts of the scientific method, while removing the rigidity of drug development, Entoura aims to get products and services to market faster, while constantly researching and improving it.
As Dr. Brighthope explains, “Medicinal cannabis will positively affect many industries, the health of humanity, and the planet. It is a potential sink for carbon, as a rapidly growing crop that can be used to produce bricks, roads and many other materials that are stronger and less combustible than plastics. The products are Generally Regarded as Environmentally Friendly (GRAF).
“Cannabis is far safer than opioids, paracetamol, aspirin, and is a safer anti-inflammatory than cortisone. It is also not addictive.
“There is a very wide range of medications being replaced by cannabis. In Canada there are good records for the reduction in the use of alcohol, tobacco, and many pharmaceuticals.
“It is a real disrupter, especially in areas such as chronic degenerative disorders, where medicine is a failure.
“I have seen a lot of change in healthcare practices over 40+ years as a healthcare professional. I am hopeful that younger generations can adopt some of the positive changes occuring in terms of nutrition, exercise, and looking after themselves and the planet.”
Cannabis is a complicated plant, with over 400 compounds. The most well known are THC, for its psychoactive effects, and CBD, for its anti-inflammatory and pain-relieving effects.
Dr. Brighthope says Entoura will be looking at every aspect: from the genetics of the seed, to the genetics of the patient, and the patient’s disease.
“This means examining their specific cancer cells, which can have many different individual genotypes. Quantum computers will be required to look at the relationship of the cancer genes, their microenvironment and the epigenetic influence of the expression of the genes of the plant. This is truly highly personalised medicine.
“The future of healthcare and disease management is at the molecular level, with preventive, predictive and personalised healthcare.”
“Natural therapists, and traditional Chinese practitioners have been doing this for eons. We want to take into account the energetic effects of the plant’s components including all the cannabinoids, terpenes, soil composition and light…. everything involved.”
Cannabinoids provide most of the health benefits, but terpenes and flavonoids help enhance those therapeutic effects, as well as providing individual health benefits. Terpenes have been shown to have analgesic or anti-inflammatory effects, while flavonoids also benefit the immune system.
Entoura says the total composition of the cannabis plant is also responsible for what has been called the ‘entourage’ effect, whereby the individual components work together to enhance and multiply their respective benefits.
From Dr. Brighthope’s perspective, “We do not need to reinvent the wheel. Pharmacologists will extract single molecules and expect them to do the same as a complex medicine with multiple molecules. This doesn’t work well. We need to apply the best clinical science of herbal medicine.
“We cannot wait for decades until the researchers prove everything we may ideally want to know about the plant. There is an abundance of high quality evidence to support the safe and effective use of medicinal cannabis now. We cannot leave people to suffer and die prematurely when millions around the world are using it..
“It is one of the safest herbal medicines, and something which doesn’t cause addiction, violent behaviour or death.”
As an integrative medicine practitioner, Dr. Brighthope believes that diet, exercise, and looking after yourself are equally important as medicinal products when treating patients.
In his words, “Complementary medicine doesn’t mean very much to me – ‘complementary’ comes from the word ‘complete’, and if you don’t complete your treatments with a patient then you’re practicing in a negligent fashion. ‘Integrative’ means integrating all healthcare practices and medical practices that are proven, safe, effective, inexpensive and ethical. And that means using not only Western medicine and the usual medications, but also incorporating nutritional medicine, scientifically-based herbal medicine, physical medicine and physiotherapy, chiropractic therapy and acupuncture, amongst other modalities.
“We incorporated all of this into our practice, and the best word to describe it was ‘integrative’. I had a business called BioCenters Integrative Medicine, and when the College of Nutritional Medicine had issues with regulators, we set up the Australasian Integrative Medicine Association (AIMA) in the mid 1990’s. Subsequent to the formation of AIMA, the term ‘integrative medicine’ went global.
“Germany has been writing on the importance of exercise for cancer patients in years: shorter hospital stays, better blood results, and improvement with patients’ well being.
“This has been known since ancient times, if someone was sick they were given certain exercises to do. There is nothing new under the stars, but researchers are now ‘discovering’ these things all the time. It is confirming what has already been known.”
Calling for change
For innovators and entrepreneurs like Dr. Ian Brighthope, Australia’s laws are behind the zeitgeist, and stifling the potential of individuals, and industry. Australian politicians call for innovation but actively suppress any realistic innovation. This occurs frequently if it is not in the pecuniary interests of mainstream.
“According to one of my colleagues, it is easier to buy a gun in Australia than it is to get legal cannabis. He has sarcastically noted that the levels of security applied to medicinal cannabis access is greater than the levels applied to prisoners breaking out of jail.”
It will take a monumental, global shift to force the politicians in Australia to move faster to open up access to medicinal cannabis, according to Dr. Brighthope.
If the United Nations were to de-schedule it as a prohibited narcotic, we may see CBD only products on Australian shelves within two years, and THC containing compounds within the next five years.
The commercialisation process is most advanced in Victoria, where there has been a hard push for policy change.
There are five million Australians suffering from chronic pain. Brighthope notes that many are addicted to opiates that result in addiction, invalidism and premature death. The other issue will be de-criminalising the driving of motorcars for patients using medically prescribed cannabis.
“Medicinal cannabis is the solution for most of these people, who by the way, don’t have a voice,” says Brighthope.
“How can you be prescribed a medicine, then be convicted and lose your license for taking it. Taking medication should not be considered a crime, especially when there are so many prescribed medicines, such as the opiates and tranquillisers that cause driving impairment.”
Undoubtedly, without a viable Australian market, it will be overseas patients that stand to benefit from Australian knowledge and ingenuity.
This piece is taken from our upcoming book, Australia's Nobel Laureates, Vol. III, celebrating Australian science and innovation. Taking a whole-of-economy healthcheck on Australia's innovation ecosystem, the book features words from industry, academia, and Government.
Getting asked what we look for in deals is one of the most common questions I get as an investment manager.
The Small Business Association of Australia is dedicated to supporting SMEs, acting as their voice to government and helping them connect, grow, and prosper well into the future.
Sensibles may sound like science fiction, but this revolutionary technology is making waves in aged-care facilities, and has the potential to transform health monitoring at scale.
Alice Springs and the deserts of Central Australia don’t sound like a food basket, but they are for businesswoman and bush foods innovator Rayleen Brown.
A new report aims to lay the foundations for a deeper and more meaningful and equitable relationship between Indigenous and non-Indigenous Australians in the mining transition sector.
If the health and medical research sector in Australia is to move forward, it must address gender equity, diversity, and inclusion- which means making the sector a safe and inclusive workspace for all.
A ground-breaking sheep technology system is bettering the businesses and lives of Australian sheep breeders thanks to a revolutionary combination of software, hardware, and support never before combined into one cohesive unit.
ANCA took an early view to look beyond Australia’s shores whilst developing advanced manufacturing technologies now viewed as ‘business as usual’
As Australia grapples with a critical skills shortage, many are now encouraging young people to embrace a career in the trades, where a wealth of opportunities awaits.
In 2016 I published a blog article titled Moonshots for Australia: 7 For Now. It’s one of many I have posted on business and innovation in Australia. In that book, I highlighted a number of Industries of the Future among a number of proposed Moonshots. I self-published a book, Innovation in Australia – Creating prosperity for future generations, in 2019, with a follow-up COVID edition in 2020. There is no doubt COVID is causing massive disruption. Prior to COVID, there was little conversation about National Sovereignty or supply chains. Even now, these topics are fading, and we remain preoccupied with productivity and jobs! My motivation for this writing has been the absence of a coherent narrative for Australia’s business future. Over the past six years, little has changed. The Australian ‘psyche’ regarding our political and business systems is programmed to avoid taking a long-term perspective. The short-term nature of Government (3 to 4-year terms), the short-term horizon of the business system (driven by shareholder value), the media culture (infotainment and ‘gotcha’ games), the general Australian population’s cynical perspective and a preoccupation with a lifestyle all create a malaise of strategic thinking and conversation. Ultimately, it leads to a leadership vacuum at all levels. In recent years we have seen the leadership of some of our significant institutions failing to live up to the most basic standards, with Royal Commissions, Inquiries and investigations consuming excessive time and resources. · Catholic Church and other religious bodies · Trade Unions · Banks (and businesses generally, take casinos, for example) · the Australian Defence Force · the Australian cricket teams · our elected representatives and the staff of Parliament House As they say, “A fish rots from the head!” At best, the leadership behaviour in those institutions could be described as unethical and, at worst….just bankrupt! In the last decade, politicians have led us through a game of “leadership by musical chairs” – although, for now, it has stabilised. However, there is still an absence of a coherent narrative about business and wealth creation. It is a challenge. One attempt to provide such a narrative has been the Intergenerational Reports produced by our federal Government every few years since 2002. The shortcomings of the latest Intergenerational Report Each Intergenerational Report examines the long-term sustainability of current government policies and how demographic, technological, and other structural trends may affect the economy and the budget over the next 40 years. The fifth and most recent Intergenerational Report released in 2021 (preceded by Reports in 2002, 2007, 2010 and 2015) provides a narrative about Australia’s future – in essence, it is an extension of the status quo. The Report also highlights three key insights: 1. First, our population is growing slower and ageing faster than expected. 2. The Australian economy will continue to grow, but slower than previously thought. 3. While Australia’s debt is sustainable and low by international standards, the ageing of our population will pressure revenue and expenditure. However, its release came and went with a whimper. The recent Summit on (what was it, Jobs and Skills and productivity?) also seems to have made the difference of a ‘snowflake’ in hell in terms of identifying our long-term challenges and growth industries. Let’s look back to see how we got here and what we can learn. Australia over the last 40 years During Australia’s last period of significant economic reform (the late 1980s and early 1990s), there was a positive attempt at building an inclusive national narrative between Government and business. Multiple documents were published, including: · Australia Reconstructed (1987) – ACTU · Enterprise Bargaining a Better Way of Working (1989) – Business Council of Australia · Innovation in Australia (1991) – Boston Consulting Group · Australia 2010: Creating the Future Australia (1993) – Business Council of Australia · and others. There were workshops, consultations with industry leaders, and conferences across industries to pursue a national microeconomic reform agenda. Remember these concepts? · global competitiveness · benchmarking · best practice · award restructuring and enterprising bargaining · training, management education and multiskilling. This agenda was at the heart of the business conversation. During that time, the Government encouraged high levels of engagement with stakeholders. As a result, I worked with a small group of training professionals to contribute to the debate. Our contribution included events and publications over several years, including What Dawkins, Kelty and Howard All Agree On – Human Resources Strategies for Our Nation (published by the Australian Institute of Training and Development). Unfortunately, these long-term strategic discussions are nowhere near as prevalent among Government and industry today. The 1980s and 1990s were a time of radical change in Australia. It included: · floating the $A · deregulation · award restructuring · lowering/abolishing tariffs · Corporatisation and Commercialisation Ross Garnaut posits that the reforms enabled Australia to lead the developed world in productivity growth – given that it had spent most of the 20th century at the bottom of the developed country league table. However, in his work, The Great Reset, Garnaut says that over the next 20 years, our growth was attributable to the China mining boom, and from there, we settled into “The DOG days” – Australia moved to the back of a slow-moving pack! One unintended consequence of opening our economy to the world is the emasculation of the Australian manufacturing base. The manic pursuit of increased efficiency, lower costs, and shareholder value meant much of the labour-intensive work was outsourced. Manufacturing is now less than 6% of our GDP , less than half of what it was 30 years ago!
